Variant report
Variant | nsv886123 |
---|---|
Chromosome Location | chr6:68410039-68486914 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:13)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:68483403..68485670-chr6:68597491..68600005,2 | K562 | blood: | |
2 | chr6:68462396..68466041-chr6:68466528..68469791,3 | K562 | blood: | |
3 | chr6:68413174..68415186-chr6:68423979..68425964,2 | K562 | blood: | |
4 | chr6:68474050..68477603-chr6:68477987..68481282,3 | K562 | blood: | |
5 | chr6:68413174..68415186-chr6:68423979..68425964,2 | K562 | blood: | |
6 | chr6:68443772..68446590-chr6:68448877..68451685,2 | K562 | blood: | |
7 | chr6:68412434..68414327-chr6:68587582..68589254,2 | K562 | blood: | |
8 | chr6:68443772..68446590-chr6:68448877..68451685,2 | K562 | blood: | |
9 | chr6:68468665..68470415-chr6:68479516..68482375,2 | K562 | blood: | |
10 | chr6:68468665..68470415-chr6:68479516..68482375,2 | K562 | blood: | |
11 | chr6:68427555..68429805-chr6:68594951..68597288,2 | K562 | blood: | |
12 | chr6:68474050..68477603-chr6:68477987..68481282,3 | K562 | blood: | |
13 | chr6:68462396..68466041-chr6:68466528..68469791,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000227706 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557679181 | chr6:68426808-68426809 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150964325 | chr6:68426812-68426813 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369352145 | chr6:68426821-68426822 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567079620 | chr6:68426824-68426825 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545770942 | chr6:68426901-68426902 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9354619 | chr6:68426904-68426905 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs553751312 | chr6:68426953-68426954 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572863655 | chr6:68426960-68426961 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183256193 | chr6:68427062-68427063 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561846764 | chr6:68427073-68427074 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373427513 | chr6:68427118-68427119 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530613632 | chr6:68427140-68427141 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs186813186 | chr6:68427156-68427157 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563998098 | chr6:68427166-68427167 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558566631 | chr6:68427182-68427183 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533061109 | chr6:68427204-68427205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142044370 | chr6:68427230-68427231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559019392 | chr6:68427231-68427232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565921065 | chr6:68427302-68427303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528514665 | chr6:68427364-68427365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377043646 | chr6:68427378-68427379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191579822 | chr6:68430814-68430815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573264141 | chr6:68430860-68430861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534150022 | chr6:68430883-68430884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs57856606 | chr6:68430884-68430885 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs182393714 | chr6:68430967-68430968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536332483 | chr6:68430984-68430985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112604593 | chr6:68431000-68431001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576227823 | chr6:68431001-68431002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552420911 | chr6:68431026-68431027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144307767 | chr6:68431068-68431069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111640716 | chr6:68431138-68431139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113495917 | chr6:68431167-68431168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187372470 | chr6:68431188-68431189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540992424 | chr6:68431204-68431205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560735994 | chr6:68431221-68431222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9346062 | chr6:68431222-68431223 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs114000063 | chr6:68431239-68431240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549879795 | chr6:68431257-68431258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141142057 | chr6:68431271-68431272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570844194 | chr6:68431350-68431351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs59483936 | chr6:68431353-68431354 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs13212071 | chr6:68431386-68431387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575219586 | chr6:68432217-68432218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559299386 | chr6:68432223-68432224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543414166 | chr6:68432232-68432233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113899080 | chr6:68432348-68432349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562694455 | chr6:68432377-68432378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370318728 | chr6:68432379-68432380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112527663 | chr6:68432381-68432382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:68426800-68427000 | Active TSS | K562 | blood |
2 | chr6:68426800-68427200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr6:68427000-68427200 | Flanking Active TSS | K562 | blood |
4 | chr6:68427200-68427400 | Enhancers | K562 | blood |
5 | chr6:68430800-68431400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr6:68432200-68432600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr6:68432600-68433200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:68432600-68433200 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr6:68432600-68433400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr6:68432800-68433200 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr6:68432800-68433400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr6:68433000-68433400 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr6:68433200-68434800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr6:68443800-68444400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr6:68446200-68447400 | Enhancers | HUVEC | blood vessel |
16 | chr6:68468600-68469000 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin01 | Skin |
17 | chr6:68468800-68469200 | Active TSS | Fetal Heart | heart |
18 | chr6:68475600-68477000 | Enhancers | HUVEC | blood vessel |